Skip to main content
. 2019 Mar 20;15(3):169–177. doi: 10.1007/s13181-019-00704-3

Table 1.

CPCS cases reporting the use of ECMO/ECLS

Year Age (gender) Substances Route of exposure Adverse clinical effects Treatments Survival Time to ECMO from ED arrival Duration of ECMO ECMO-related complications Did ECMO contribute to death?
1998 1 year (male) Hydrocarbon furniture polish Oral

Acidosisa

Aspiration

Pneumothorax

Intubation

VV ECMO

Yes 3 days 21 days None reported Not applicable
2001 1 month (male) Digoxin IV

Ventricular-tachycardia (Vtach)/ventricular-fibrillation (Vfib)

Asystole

Digoxin antibodies

Cardioversion

Cardiopulmonary resuscitation (CPR)

VA ECMO

No < 1 day < 1 day None reported No
2001 9 years (male) Imipramine Oral

Hypotensionb

Ventricular-fibrillation

Transvenous pacer

Vasopressors

VA ECMO

Yes 2 days 8 days None reported Not applicable
2008 1 year (male) Lamp Oil Oral

Hypotensionb

Hypoxia

Respiratory arrest

Aspiration

Intubation

Vasopressor

VV ECMO

Yes < 1 day 6 days None reported Not applicable
2009 2 years (male)

Digoxin

Flecainide

Oral

Hypotensionb

Bradycardiac

Vtach/Vfib

Seizures

Asystole

Digoxin antibodies

Vasopressors Intubation

VA ECMO

Yes < 1 day 3 days None reported Not applicable
2010 17 years (male)

Atenolol

Amlodipine

Colchicine

Oral

Hypotensionb

Pulmonary edema

Renal failured

Asystole

Calcium

Glucagon

Vasopressors

VA ECMO

No 2 days < 1 day None reported No
2011 45 years (male)

Arsenic trioxide

White phosphorous

Dermal

Inhalation

Hypotensionb

Vtach

Cyanosis

Vasopressors

Hemodialysis

Intubation

VA ECMO

Yes 2 days 11 days None reported Not applicable
2012 22 years (male) Methylenedioxymethamphetamine Oral

Hyperthermiae

Acidosisa

Ast and/or Alt > 1000

Renal failured

Rhabdomyolysisf

Multiple seizures

Coma

Vasopressors

Hemodialysis

Intubation

VA ECMO

Yes 1 day 2 days Compartment syndrome at cannulation site requiring fasciotomy of right leg resulting in infection Not applicable
2012 54 years (female) Diltiazem Oral

Hypotensionb

Bradycardiac

Calcium

Glucagon

Vasopressors

High-dose insulin

Intralipid

Intubation

VA ECMO

Yes < 1 day 2 days None reported Not applicable
2013 7 months (male) Flecainide Oral

Vtach/Vfib

Asystole

Vasopressors

Intralipid

Intubation

CPR

VA ECMO

Yes < 1 day 2 days None reported Not applicable
2013 26 years (male) Diltiazem Oral

Hypotensionb

Bradycardiac

Coma

Asystole

Glucagon

Vasopressors

High-dose insulin

Intralipid

Transvenous pacing

Intubation

VA ECMO

Yes < 1 day 2 days None reported Not applicable
2014 17 years (male) Amlodipine Oral

Hypotensionb

Respiratory arrest

Asystole

Vasopressors

Intubation

VA ECMO

Yes 1 day unknown None reported Not applicable
2014 1 year (female) Hydrocarbon furniture polish Oral

Hypotensionb

Aspiration

Asystole

Vasopressors

Intubation

CPR

VV ECMO

No < 1 day < 1 day 5 min asystolic arrest during cannulation Unknown
2015 27 years (male)

Cocaine

Ethanol

Oral

Insufflation

Hypotensionb

Respiratory arrest

Coma

Vasopressors

Intubation

VA ECMO

Yes < 1 day 6 days None reported Not applicable
2016 17 years (female)

Diltiazem

Metoprolol

IV

Hypotensionb

Asystole

Glucagon

Calcium

Vasopressors

Intubation

CPR

VA ECMO

Yes < 1 day 1 day None reported Not applicable
2016 24 years (male) Fentanyl Oral

Acidosisa

Respiratory arrest

Intubation

VV ECMO

Yes < 1 day 3 days None reported Not applicable

aAcidosis defined as serum bicarbonate < 20 mEq/L (mmol/L), pH < 7.35, or elevated lactic acid levels

bHypotension defined in adults as blood pressure < 90 mmHg systolic or more than 15 mmHg less than patient’s usual systolic blood pressure. In children, systolic blood pressure < (70 + 2(age)) mmHg

cBradycardia defined as heart rate < 60 beats per minute in adults. Age-related standards applied to children

dRenal failure defined as impairment that has produced clinically significant azotemia and loss of renal function

eHyperthermia defined as temperature ≥ 38 °C

fRhabdomyolysis defined as presence of myoglobin in the urine or a creatinine kinase (CK) level > 500 IU/L